FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:165-171 January 20, 1994 Number 3 Next

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Transjugular placement of an intrahepatic stent is a new technique to establish a portosystemic shunt for treatment of portal hypertension. A puncture needle is advanced in a catheter through the inferior vena cava into a hepatic vein; then an intrahepatic branch of the portal vein is punctured and an expandable stent of metallic mesh is implanted to establish the shunt.

Methods We attempted the stent-shunt procedure in 100 of 112 consecutive patients with variceal bleeding due to cirrhosis, who were then followed for a mean (±SD) of 12 ±6 months. Of the 100 patients, 22 had Child-Pugh class C cirrhosis, 10 were treated on an emergency basis, and 68 had alcoholic cirrhosis. The shunt was established with use of Palmaz stents expanded to 8 to 12 mm in diameter.

Results Technical success was achieved in 93 percent of the patients. The mean (±SD) time for the procedure was 1.2 ±0.3 hours. The shunt reduced the portal venous pressure gradient by 57 percent. Major complications were hemorrhage (intraabdominal bleeding in six patients, biliary bleeding in four, and bleeding in the liver capsule in three) and migration of the stent into the pulmonary artery (in two patients). At follow-up, stenosis of the shunt was evident in 21 patients and occlusion in 10 patients; 10 of these 31 patients had variceal rebleeding. Stenoses and occlusions of the shunt were all treated successfully by redilation, thrombolysis, or implantation of an additional stent. Hepatic encephalopathy (stages I to III) developed in 25 percent of the patients.

The proportion of patients with shunts who remained free of variceal rebleeding was 92 percent at six months and 82 percent at one year. The 30-day mortality was 3 percent. The cumulative one-year survival was 85 percent.

Conclusions These results suggest that the transjugular placement of an intrahepatic portosystemic stent is an effective and safe treatment for variceal hemorrhage in patients with portal hypertension due to cirrhosis.

Source Information

From the Medizinische Universitatsklinik (M.R., K. Haag, A.O., M.S., E.B., W.G.) and the Radiologische Universitatsklinik (G.N., U.B., A.G., K. Hauenstein, M.L.), Freiburg, Germany; and the Hopital de Bon-Secours, Metz, France (J.-M.P.).

Address reprint requests to Dr. Rossle at the Medizinische Universitatsklinik, Hugstetterstr. 55, 79106 Freiburg, Germany.

Full Text of this Article

This article has been cited by other articles:

• Holland-Fischer, P., Vilstrup, H., Frystyk, J., Nielsen, D. T., Flyvbjerg, A., Gronbaek, H. (2009). The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis. Eur J Endocrinol 160: 957-963 [Abstract] [Full Text]  
• Park, S W, Lee, S H, Kim, C H, Jeon, G S, Hong, S J, Yi, J G, Jeon, H J (2007). Inhibition of pseudointimal hyperplasia in swine TIPS models: the efficacy of local delivery of paclitaxel using a perforated balloon catheter. Br. J. Radiol. 80: 702-707 [Abstract] [Full Text]  
• Elwood, D. R., Pomposelli, J. J., Pomfret, E. A., Lewis, W. D., Jenkins, R. L. (2006). Distal Splenorenal Shunt: Preferred Treatment for Recurrent Variceal Hemorrhage in the Patient With Well-Compensated Cirrhosis. Arch Surg 141: 385-388 [Abstract] [Full Text]  
• Yoon, C. J., Chung, J. W., Park, J. H. (2005). Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding in Patients with Viral Liver Cirrhosis: Predictors of Early Mortality. Am. J. Roentgenol. 185: 885-889 [Abstract] [Full Text]  
• Tesdal, I. K., Filser, T., Weiss, C., Holm, E., Dueber, C., Jaschke, W. (2005). Transjugular Intrahepatic Portosystemic Shunts: Adjunctive Embolotherapy of Gastroesophageal Collateral Vessels in the Prevention of Variceal Rebleeding. Radiology 236: 360-367 [Abstract] [Full Text]  
• Ninoi, T., Nishida, N., Kaminou, T., Sakai, Y., Kitayama, T., Hamuro, M., Yamada, R., Nakamura, K., Arakawa, T., Inoue, Y. (2005). Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices with Gastrorenal Shunt: Long-Term Follow-Up in 78 Patients. Am. J. Roentgenol. 184: 1340-1346 [Abstract] [Full Text]  
• Ninoi, T., Nakamura, K., Kaminou, T., Nishida, N., Sakai, Y., Kitayama, T., Hamuro, M., Yamada, R., Arakawa, T., Inoue, Y. (2004). TIPS Versus Transcatheter Sclerotherapy for Gastric Varices. Am. J. Roentgenol. 183: 369-376 [Abstract] [Full Text]  
• Hur, J., Lee, K.-H., Lee, J. H., Yu, J.-S., Won, J. Y., Lee, D.-Y. (2004). Stent-Graft for TIPS in a Hepatocellular Carcinoma Patient with Main Portal Vein Invasion. Am. J. Roentgenol. 182: 1301-1304 [Full Text]  
• ter Borg, P. C. J., Hollemans, M., van Buuren, H. R., Vleggaar, F. P., Groeneweg, M., Hop, W. C. J., Lameris, J. S. (2004). Transjugular Intrahepatic Portosystemic Shunts: Long-term Patency and Clinical Results in a Patient Cohort Observed for 3-9 Years. Radiology 231: 537-545 [Abstract] [Full Text]  
• Wallace, M. J., Ahrar, K., Stephens, L. C., Wright, K. C. (2003). Transvenous Extrahepatic Portacaval Shunt: Feasibility Study in a Swine Model. Radiology 228: 119-125 [Abstract] [Full Text]  
• Angermayr, B, Cejna, M, Karnel, F, Gschwantler, M, Koenig, F, Pidlich, J, Mendel, H, Pichler, L, Wichlas, M, Kreil, A, Schmid, M, Ferlitsch, A, Lipinski, E, Brunner, H, Lammer, J, Ferenci, P, Gangl, A, Peck-Radosavljevic, M (2003). Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52: 879-885 [Abstract] [Full Text]  
• Bellis, L, Moitinho, E, Abraldes, J G, Graupera, M, Garcia-Pagan, J C, Rodes, J, Bosch, J (2003). Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Gut 52: 130-133 [Abstract] [Full Text]  
• Wong, L. L., Lorenzo, C., Limm, W. M., Wong, L. M. (2002). Splenorenal Shunt: An Ideal Procedure in the Pacific. Arch Surg 137: 1125-1129 [Abstract] [Full Text]  
• Hidajat, N., Stobbe, H., Hosten, N., Schroeder, R.-J., Fauth, M., Vogl, T., Felix, R. (2002). Transjugular Intrahepatic Portosystemic Shunt and Transjugular Embolization of Bleeding Rectal Varices in Portal Hypertension. Am. J. Roentgenol. 178: 362-363 [Full Text]  
• Wald, H. L., Aronson, M. D. (2001). Update in Hospital Medicine. ANN INTERN MED 135: 1052-1060 [Full Text]  
• Pomier-Layrargues, G, Villeneuve, J-P, Deschenes, M, Bui, B, Perreault, P, Fenyves, D, Willems, B, Marleau, D, Bilodeau, M, Lafortune, M, Dufresne, M-P (2001). Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 48: 390-396 [Abstract] [Full Text]  
• Helton, W. S., Maves, R., Wicks, K., Johansen, K. (2001). Transjugular Intrahepatic Portasystemic Shunt vs Surgical Shunt in Good-Risk Cirrhotic Patients: A Case-Control Comparison. Arch Surg 136: 17-20 [Abstract] [Full Text]  
• Daves, S. M. (2000). The Liver and Vascular Surgery. SEMIN CARDIOTHORAC VASC ANESTH 4: 275-288 [Abstract]  
• Brensing, K A, Textor, J, Perz, J, Schiedermaier, P, Raab, P, Strunk, H, Klehr, H U, Kramer, H J, Spengler, U, Schild, H, Sauerbruch, T (2000). Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47: 288-295 [Abstract] [Full Text]  
• Zizka, J., Elias, P., Krajina, A., Michl, A., Lojik, M., Ryska, P., Maskova, J., Hulek, P., Safka, V., Vanasek, T., Bukac, J. (2000). Value of Doppler Sonography in Revealing Transjugular Intrahepatic Portosystemic Shunt Malfunction: A 5-Year Experience in 216 Patients. Am. J. Roentgenol. 175: 141-148 [Abstract] [Full Text]  
• Rossle, M., Ochs, A., Gulberg, V., Siegerstetter, V., Holl, J., Deibert, P., Olschewski, M., Reiser, M., Gerbes, A. L. (2000). A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites. NEJM 342: 1701-1707 [Abstract] [Full Text]  
• Plauth, M, Roske, A-E, Romaniuk, P, Roth, E, Ziebig, R, Lochs, H (2000). Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration. Gut 46: 849-855 [Abstract] [Full Text]  
• JALAN, R, LUI, H F, REDHEAD, D N, HAYES, P C (2000). TIPSS 10 years on. Gut 46: 578-581 [Full Text]  
• Huonker, M, Schumacher, Y O, Ochs, A, Sorichter, S, Keul, J, Rossle, M (1999). Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 44: 743-748 [Abstract] [Full Text]  
• Riordan, S. M., Williams, R. (1997). Treatment of Hepatic Encephalopathy. NEJM 337: 473-479 [Full Text]  
• Tyburski, J. G., Noorily, M. J., Wilson, R. F. (1997). Prognostic Factors With the Use of the Transjugular Intrahepatic Portosystemic Shunt for Bleeding Varices. Arch Surg 132: 626-631 [Abstract]  
• Miller-Catchpole, R. (1995). Transjugular Intrahepatic Portosystemic Shunt (TIPS) Diagnostic and Therapeutic Technology Assessment (DATTA). JAMA 273: 1824-1830 [Abstract]  
• Ochs, A., Rossle, M., Haag, K., Hauenstein, K.-H., Deibert, P., Siegerstetter, V., Huonker, M., Langer, M., Blum, H. E. (1995). The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Refractory Ascites. NEJM 332: 1192-1197 [Abstract] [Full Text]  
• Rikkers, L. F., Jin, G. (1995). Emergency Shunt: Role in the Present Management of Variceal Bleeding. Arch Surg 130: 472-477 [Abstract]  
• Grace, N. D. (1994). The Side-to-Side Portacaval Shunt Revisited. NEJM 330: 208-209 [Full Text]